Latest News

Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma, psoriatic arthritis, and vasculitis.

F. Perry Wilson, MD, MSCE, discusses what to look for when choosing a primary care doctor.

A new study from Yale Department of Internal Medicine’s Section of Rheumatology, Allergy & Immunology and the Department of Surgery’s Division of Vascular Surgery and Endovascular Therapy described the use of hyperspectral imaging (HSI) to measure oxygenated and deoxygenated hemoglobin concentrations and oxygen saturation. In systemic sclerosis patients with Raynaud phenomenon, this technology may help quantify disease severity.

Groundbreaking clinical research at ACC 23.

Automated alerts sent to clinicians via patients' electronic health records (EHRs) identified patients with diagnosable acute kidney injury (AKI) who were taking one or more medications that could potentially further worsen their renal function. This led to a significant increase in discontinuations of the problematic drugs and better clinical outcomes in a subgroup of patients in a new multicenter, randomized study with more than 5000 participants.

Recent developments from the Section of Cardiovascular Medicine.

Guideline-directed medical therapies are under-utilized. Two trainees developed an interactive consult tool to provide guidance at each stage of kidney disease.

The Section of Cardiovascular Medicine published research in American Heart Journal, JAMA Internal Medicine, and JAMA Cardiology.

The Heart Failure Society of America (HFSA) Annual Scientific Meeting will take place in Washington, D.C. from September 30, 2022 to October 3, 2022.